Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 35 | 0 | 2 | 0 | 137,55 € | 236,30 € | 71,79 % |
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | 134,10 € | 137,63 € | 2,64 % |
| Icon plc | 18 | 0 | 6 | 0 | 283,60 € | 319,67 € | 12,72 % |
| United Therapeutics | 15 | 0 | 0 | 0 | 222,30 € | 289,92 € | 30,42 % |
| Exelixis Inc. | 15 | 0 | 0 | 0 | 22,15 € | 26,01 € | 17,41 % |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | 41,20 € | 82,93 € | 101,29 % |
| Insulet Corp. | 14 | 0 | 1 | 0 | 158,80 € | 215,54 € | 35,73 % |
| Merit Medical Systems | 13 | 0 | 2 | 0 | 69,50 € | 86,72 € | 24,77 % |
| Amedisys Inc. | 13 | 0 | 1 | 0 | 84,00 € | 92,26 € | 9,83 % |
| Repligen Corp. | 12 | 0 | 0 | 0 | 154,95 € | 182,96 € | 18,08 % |
| Halozyme Therapeutics Inc. | 12 | 0 | 1 | 0 | 36,53 € | 54,21 € | 48,40 % |
| Alkermes plc | 12 | 2 | 2 | 0 | 23,00 € | 34,08 € | 48,18 % |
| CONMED Corp. | 11 | 1 | 3 | 0 | 61,00 € | 109,59 € | 79,65 % |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | 373,50 € | 421,61 € | 12,88 % |
| QIAGEN NV | 9 | 0 | 0 | 0 | 40,47 € | 47,44 € | 17,22 % |
| Ensign Group Inc. | 8 | 0 | 1 | 0 | 110,00 € | 116,50 € | 5,91 % |
| Xencor Inc. | 9 | 1 | 1 | 0 | 18,70 € | 31,74 € | 69,73 % |
| Bio-Techne Corp. | 8 | 0 | 0 | 0 | 60,50 € | 75,80 € | 25,29 % |
| MorphoSys AG | 7 | 0 | 0 | 0 | 65,35 € | 65,00 € | -0,54 % |
| Gerresheimer AG | 7 | 0 | 1 | 0 | 100,60 € | 110,00 € | 9,34 % |
| LivaNova plc | 7 | 0 | 1 | 0 | 51,00 € | 64,66 € | 26,78 % |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | 110,40 € | - | - |
| Bruker Corp. | 7 | 1 | 0 | 1 | 75,82 € | 85,68 € | 13,01 % |